These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3907826)

  • 1. Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
    Einzig A; Kelsen DP; Cheng E; Sordillo P; Heelan R; Winn R; Magill G
    Cancer Treat Rep; 1985 Dec; 69(12):1453-4. PubMed ID: 3907826
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
    Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of carboplatin in non-small cell lung cancer.
    Olver IN; Donehower RC; Van Echo DA; Ettinger DS; Aisner J
    Cancer Treat Rep; 1986 Mar; 70(3):421-2. PubMed ID: 3513947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
    Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
    Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
    Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited activity of carboplatin in malignant lymphoma.
    Danieu L; Warrell RP
    Cancer Treat Rep; 1986 Jul; 70(7):931-2. PubMed ID: 3521851
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
    Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
    Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phase II study of carboplatin in malignant lymphoma].
    Naito K; Kobayashi M; Oyama A; Kodera Y; Tanaka M; Kamiya O; Mitomo Y; Ohno R; Sampi K; Hirano M
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2145-51. PubMed ID: 3293537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin for advanced colorectal carcinoma: a phase II study.
    Perry DJ; Weiss RB; Creekmore SP; Micetich KC; Curt GA
    Cancer Treat Rep; 1986 Feb; 70(2):301-2. PubMed ID: 3512081
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.
    Goldenberg AS; Kelsen D; Dougherty J; Magill G
    Invest New Drugs; 1990 Feb; 8(1):71-5. PubMed ID: 2345073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of carboplatin in advanced or metastatic stomach cancer.
    Beer M; Cavalli F; Kaye SB; Lev LM; Clavel M; Smyth J; van Glabbeke M; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1565-7. PubMed ID: 3315695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours].
    Mathé G; Serrou B; Hayat M; De Vassal F; Misset JL; Schwarzenberg L; Machover D; Ribaud P; Belpomme D; Jasmin C; Musset M; Montero JL; Imbach JL
    Biomedicine; 1977 Nov; 27(8):294-7. PubMed ID: 339971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodostearic acid in the treatment of advanced gastrointestinal carcinoma.
    Kelly SB; Cooper J; Llewellyn S; Khoo DE; Virjee J; Wood CB; Williamson RC; Habib NA
    Eur J Surg Oncol; 1992 Aug; 18(4):357-61. PubMed ID: 1521629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of carboplatin in adenocarcinoma of the oesophagus.
    Steel A; Cullen MH; Robertson PW; Matthews HR
    Br J Cancer; 1988 Oct; 58(4):500-1. PubMed ID: 3061440
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of carboplatin in advanced endometrial carcinoma.
    Long HJ; Pfeifle DM; Wieand HS; Krook JE; Edmonson JH; Buckner JC
    J Natl Cancer Inst; 1988 Apr; 80(4):276-8. PubMed ID: 3280811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cochleovestibular function in patients treated with carboplatin for ovarian carcinoma.
    Ragni N; Foglia G; Ruvolo M; Repetto P; Cordone G; Madaro M; Chiara S; Bruzzone M
    Chemioterapia; 1986 Dec; 5(6):411-3. PubMed ID: 3542253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-induced pancreatitis: a case series.
    Butt W; Saadati H; Saif MW
    Anticancer Res; 2010 Dec; 30(12):5113-5. PubMed ID: 21187498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
    Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
    Cancer Treat Rep; 1985 Nov; 69(11):1305-7. PubMed ID: 3912041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
    Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
    Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer].
    Xu RH; Guan ZZ; Jiang WQ; Huang H; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C; Ma ZY; Wang JH
    Ai Zheng; 2002 Dec; 21(12):1354-8. PubMed ID: 12520747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.